Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Ono

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Ono's Japan sales performance.

Hudson named Brandicourt’s successor as Sanofi’s CEO

Hudson named Brandicourt’s successor as Sanofi’s CEO 51-year-old Hudson is a “seasoned leader with a strong international experience, particularly in the US, Japan and Europe,” said Sanofi in its statement to announce the succession this morning.

Countries hail ‘landmark’ drug pricing transparency resolution, despite watering down

Countries hail ‘landmark’ drug pricing transparency resolution, despite watering down The US, Japan and Switzerland agreed to support price transparency proposals, but opposed transparency in regard to R&D costs.

Novartis secures US approval - and payers’ blessing – for $2m gene therapy Zolgensma

Novartis secures US approval - and payers’ blessing – for $2m gene therapy Zolgensma Zolgensma is expected to gain approval in the EU and Japan in the coming months, where similar financing deals are being discussed.

Research charity LifeArc cashes $1.2bn royalty from Keytruda

Research charity LifeArc cashes $1.2bn royalty from Keytruda In March it formed a cancer immunotherapy alliance with CRUK and Ono Pharma, in April it licensed an ion channel drug discovery programme to Daiichi Sankyo, and in early May it

One hit, one miss as FDA panel votes on Daiichi’s cancer drugs

One hit, one miss as FDA panel votes on Daiichi’s cancer drugs positive relapsed AML – Xospata (gilteritinib) – which picked up an FDA approval in this setting last November and was launched in Japan last December.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics